Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing Signs First Customer for SNP Analysis Program

NEW YORK, Feb 5 - Pyrosequencing of Uppsala, Sweden said Monday the Wallenberg Consortium North was the first customer to sign up for its Preferred Technology Program for the analysis of SNPs.

The WCN, a consortium that includes the proteomics, bioinformatics, and genomics branches of Sweden’s Royal Institute of Technology, the Karolinska Institute, the University of Uppsala, the University of Stockholm, and the University of Umea, intends to use the PTP to analyze SNPs associated with human and animal diseases. The consortium has committed $200 million for genomics research over the next five years.

Financial terms of the deal were not disclosed.

" What is particularly attractive about PTP is its highly customized offering which meets our specific needs – from sample preparation robotics through to SNP scoring,” Joakim Lundeberg, director of the Royal Institute of Technology’s genome center, said in a statement. “Going forward, it also allows us to ramp up our capacity to analyze samples using the same Pyrosequencing technology."

Pyrosequencing's PTP is a high-throughput system that runs on 384 well microplates and can score up to to 100,000 SNPs a day, the company said. The system uses the same “sequencing by synthesis” employed in the company’s PSQ 96 system. PTP also includes software, reagent kits, and sample preparation robotics.

" PTP is a truly collaborative offering in which we work closely with customers like the Wallenberg Consortium to assess their sequencing needs and customize our product to meet special requirements,” said Erik Wallden, CEO of Pyrosequencing.

Pyrosequencing’s customers for the PSQ 96 include AstraZeneca, Harvard Center for Cancer Prevention and the National Institutes of Health.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.